These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8101100)

  • 1. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction.
    Seidman LJ; Pepple JR; Faraone SV; Kremen WS; Green AI; Brown WA; Tsuang MT
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):575-84. PubMed ID: 8101100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smaller right ear (left hemisphere) advantage for dichotic fused words in patients with schizophrenia.
    Bruder G; Rabinowicz E; Towey J; Brown A; Kaufmann CA; Amador X; Malaspina D; Gorman JM
    Am J Psychiatry; 1995 Jun; 152(6):932-5. PubMed ID: 7755128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic dose reduction in older psychotic patients.
    Harris MJ; Heaton RK; Schalz A; Bailey A; Patterson TL
    Schizophr Res; 1997 Oct; 27(2-3):241-8. PubMed ID: 9416653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do neuroleptics impair learning in schizophrenic patients?
    Cutmore TR; Beninger RJ
    Schizophr Res; 1990; 3(3):173-86. PubMed ID: 1980612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.
    Saykin AJ; Shtasel DL; Gur RE; Kester DB; Mozley LH; Stafiniak P; Gur RC
    Arch Gen Psychiatry; 1994 Feb; 51(2):124-31. PubMed ID: 7905258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients.
    Smith RC; Largen J; Vroulis G; Ravichandran GK
    Compr Psychiatry; 1992; 33(2):139-45. PubMed ID: 1347499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in neuropsychological functioning among schizophrenic patients.
    Lewine RR; Walker EF; Shurett R; Caudle J; Haden C
    Am J Psychiatry; 1996 Sep; 153(9):1178-84. PubMed ID: 8780422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
    Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
    Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of illness duration on perceptual asymmetry in schizophrenia.
    Carr V; Wale J; Dewis S; Stephan L
    Schizophr Res; 1992 Sep; 7(3):211-6. PubMed ID: 1356424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wisconsin Card Sorting Test performance over time in schizophrenia. Preliminary evidence from clinical follow-up and neuroleptic reduction studies.
    Seidman LJ; Pepple JR; Faraone SV; Kremen WS; Cassens G; McCarley RW; Tsuang MT
    Schizophr Res; 1991 Oct; 5(3):233-42. PubMed ID: 1684721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic drug effects on cognitive function in schizophrenia.
    Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM
    Schizophr Res; 1990; 3(3):211-9. PubMed ID: 1980613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic effects on neuropsychological test performance in schizophrenia.
    Verdoux H; Magnin E; Bourgeois M
    Schizophr Res; 1995 Jan; 14(2):133-9. PubMed ID: 7710993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings.
    Finkelstein JR; Cannon TD; Gur RE; Gur RC; Moberg P
    J Abnorm Psychol; 1997 May; 106(2):203-12. PubMed ID: 9131840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.
    Goldberg TE; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 9():62-5. PubMed ID: 8823353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal laterality in schizophrenics and their parents.
    Grosh ES; Docherty NM; Wexler BE
    Schizophr Res; 1995 Jan; 14(2):155-60. PubMed ID: 7710996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology.
    Mackert A; Flechtner KM; Woyth C; Frick K
    Schizophr Res; 1991; 4(1):41-7. PubMed ID: 1672606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
    Litman RE; Su TP; Potter WZ; Hong WW; Pickar D
    Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse].
    Woggon B; Bickel P; Schnyder B
    Int Pharmacopsychiatry; 1979; 14(5):278-93. PubMed ID: 43849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.